Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ceban Pharmaceuticals is a leading international pharmaceutical compounding and services group based in the Netherlands. The company specializes in the preparation of customized medications (compounding) for hospitals, pharmacies, and individual patients, ensuring access to tailored treatments when standardized options are unavailable. In addition to its core compounding business, Ceban provides clinical trial services, pharmaceutical distribution, and wholesale through its various subsidiaries. The group operates across several European markets, including the Netherlands, Belgium, and Spain, and was recently acquired by Mediq to strengthen its position in the healthcare supply chain. Its portfolio includes specialized brands such as BModesto and Ceban Compounding, which support the delivery of high-quality pharmaceutical care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceban.